載入...
Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study
IMPORTANCE: The randomized clinical trials comparing nonvitamin K antagonist oral anticoagulants (NOACs) vs warfarin largely focused on recruiting high-risk patients with atrial fibrillation with more than 2 stroke risk factors, with only the trials testing dabigatran or apixaban including few patie...
Na minha lista:
| 發表在: | JAMA Cardiol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Medical Association
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5710590/ https://ncbi.nlm.nih.gov/pubmed/28614582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2017.1883 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|